Headline: BGRIM expects a profit increase by leaps and bounds in 2Q22
B.Grimm Power Pcl. (SET: BGRIM) expects a profit increase by leaps and bounds in 2Q22 due to the addition of 88 megawatts of production capacity from a solar farm in Malaysia. Combined with a benefit from the forthcoming hike in electric rates. In addition, the Company anticipates concluding more M&A deals, including the acquisition of two to three LNG-to-Power plants, by the end of June. Furthermore, the Company is planning to issue debentures of up to THB5-8 billion. THB44.00. Analysts recommend “BUY” with a target price of THB44.00.
Headline: GUNKUL sees robust earnings growth after entering into partnership with GULF
Gunkul Engineering Pcl. (SET: GUNKUL) anticipates the partnership with Gulf Energy Development Pcl. (SET: GULF) to add more value to the Company, particularly from electric sales and EPC contracts, and to boost the Company’s production capacity to 1,000 megawatts within five years.
Headline: Eyes on JMT and BDMS as both shares set to be included in MSCI Indexes
MSCI Inc. is poised to increase the weight of Thailand’s shares in the MSCI Indexes tomorrow (31 May). Analysts forecast around THB3.5 billion to flow into JMT Network Services Pcl. (SET: JMT) and Bangkok Dusit Medical Services (SET: BDMS). They also recommend accumulating EA, OSP, and BGRIM, which will be included in the indexes in the upcoming revision. Analysts predict that tomorrow’s daily trading volume would reach up to THB80 billion.
Headline: SMK to announce its business rehabilitation plan to shareholders on 2 June
Syn Mun Kong Insurance Pcl. (SET: SMK) has scheduled an e-meeting on 2 June for a public presentation to shareholders, investors, and associated parties. The objective of this meeting is to present the business rehabilitation plan following the Central Bankruptcy Court’s acceptance of the Company’s petition.
Headline: SAWAD anticipates loan increase of 30% due to rising motorcycle loan demand
Srisawad Corporation Pcl. (SET: SAWAD) maintains its loan growth for this year at 20-30% on the back of a THB11 billion profit generated from motorbike loans and its capacity to control NPL. Analysts recommend “BUY” with a target price of THB70.50.
Headline: IP anticipates leap growth in sale profit in 2Q22
Inter Pharma Pcl (SET: IP) is moving forward with its plan to become the market leader in healthcare product research, development, and distribution. The Company announced in mid-May the issuance of new shares to Innobic, a subsidiary of PTT Pcl. (SET: PTT), via Private Placement. Within five years, IP anticipates generating revenues of THE5 billion.
